Mark S. Ordan - Nov 21, 2022 Form 4 Insider Report for Pediatrix Medical Group, Inc. (MD)

Role: Chief Executive Officer, Director
Signature: /s/ Mary Ann E. Moore, Attorney-in-Fact
Stock symbol: MD
Transactions as of: Nov 21, 2022
Transactions value $: -$342,465
Form type: 4
Date filed: 11/23/2022, 04:00 PM
Previous filing: May 2, 2022
Next filing: Jan 4, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MD	Common Stock	Sale	-$342K	-22.2K	-6.01%	$15.45	347K	Nov 21, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $15.22 to $15.89 for a weighted average sales price of $15.45. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $15.22 to $15.89 for a weighted average sales price of $15.45. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.